论文部分内容阅读
随着我国改革开放的深入发展,国内市场空前繁荣,特别是医药工业随着形势发展更加迅猛,各类新药层出不穷,大量走向市场。这给人民的身体健康带来了很大的好处,也为我国的医药事业走向市场创出了一条新路。但是,新药不良反应发生率也不断增加。因此,药品不良反应监察(ADRM)也越来越受到药政部门的重视。我国于1988年分别在北京、上
With the deepening of China’s reform and opening up, the domestic market is unprecedentedly prosperous. In particular, as the situation in the pharmaceutical industry grows more rapidly, various types of new drugs emerge in an endless stream and a large number of markets are emerging. This has brought great benefits to the people’s health and has also created a new road for the pharmaceutical industry in our country to go to the market. However, the incidence of adverse drug reactions also continue to increase. Therefore, Drug Adverse Drug Reaction Monitoring (ADRM) is also increasingly valued by the pharmaceutical authorities. My country was in Beijing in 1988, respectively